Prognosis for seizure recurrence in patients with newly diagnosed neurocysticercosis.
Cutter
Albert C
AC
D000923:Anticestodal Agents / Q000627:therapeutic use; D006801:Humans; D020019:Neurocysticercosis / Q000150:complications / Q000175:diagnosis / Q000188:drug therapy*; D011379:Prognosis; D012008:Recurrence; D012307:Risk Factors; D012640:Seizures / Q000453:epidemiology* / Q000209:etiology
D000923:Anticestodal Agents